Form D — Ensysce Biosciences, Inc.
0001493152-26-039439 · filed Aug 20, 2026
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $77,200,000
- Total sold
- $77,200,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ensysce Biosciences, Inc.
- CIK
- 1716947
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 7946 IVANHOE AVE,
LA JOLLA, CA 92037 - Phone
- (858) 263-4196
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
D Lynn Kirkpatrick · Executive OfficerLa Jolla, CA Find on LinkedIn ↗
-
Bob Gower · DirectorLa Jolla, CA Find on LinkedIn ↗
-
William Chang · DirectorLa Jolla, CA Find on LinkedIn ↗
-
Steve Martin · DirectorLa Jolla, CA Find on LinkedIn ↗
-
Adam Levin · DirectorLa Jolla, CA Find on LinkedIn ↗
-
David Humphrey · Executive OfficerLa Jolla, CA Find on LinkedIn ↗
-
James Morrison · Executive OfficerLa Jolla, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗